Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Week, Phase 2A, Randomized, Subject And Investigator Blind, Placebo-Controlled Trial To Evaluate The Effect Of CP-741,952 On Weight Loss In Otherwise Healthy Overweight And Obese Adult Subjects

NCT00367783 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00367783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00367783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Week, Phase 2A, Randomized, Subject And Investigator Blind, Placebo-Controlled Trial To Evaluate The Effect Of CP-741,952 On Weight Loss In Otherwise Healthy Overweight And Obese Adult Subjects
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2006
Completion date
April 30, 2007
Enrollment
100
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

obesity